Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Report

Global and Region Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：143
  • REPORT CODE：GMM993253
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnosticsmarket, defines the market attractiveness level of Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics industry, describes the types of Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics market and the development prospects and opportunities of Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics market in Chapter 13.

    By Player:

    • Allergan

    • Digestive Care

    • Janssen Pharmaceuticals

    • Nordmark Arzneimittel

    • AzurRx Biopharma

    • AbbVie

    • Cilian

    • Anthera Pharmaceuticals

    By Type:

    • Therapeutics

    • Diagnostics

    By End-User:

    • Hospitals

    • Ambulatory Surgical Centers

    • Specialty Clinics

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Analysis and Outlook to 2022

    • 7.1 Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption (2017-2022)

    • 7.2 United States Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption (2017-2022)

    • 7.3 Europe Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption (2017-2022)

    • 7.4 China Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption (2017-2022)

    • 7.5 Japan Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption (2017-2022)

    • 7.6 India Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption (2017-2022)

    • 7.7 South Korea Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption (2017-2022)

    8 Region and Country-wise Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Analysis and Outlook to 2028

    • 8.1 Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption Forecast (2022-2028)

    • 8.2 United States Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption Forecast (2022-2028)

    • 8.3 Europe Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption Forecast (2022-2028)

    • 8.4 China Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption Forecast (2022-2028)

    • 8.5 Japan Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption Forecast (2022-2028)

    • 8.6 India Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption Forecast (2022-2028)

    • 8.7 South Korea Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption Forecast (2022-2028)

    9 Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Outlook by Types and Applications to 2022

    • 9.1 Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Therapeutics Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Diagnostics Consumption and Growth Rate (2017-2022)

    • 9.2 Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Specialty Clinics Consumption and Growth Rate (2017-2022)

    10 Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Outlook by Types and Applications to 2028

    • 10.1 Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Therapeutics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

    11 Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Competitive Analysis

    • 14.1 Allergan

      • 14.1.1 Allergan Company Details

      • 14.1.2 Allergan Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Allergan Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Product and Service

    • 14.2 Digestive Care

      • 14.2.1 Digestive Care Company Details

      • 14.2.2 Digestive Care Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Digestive Care Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Product and Service

    • 14.3 Janssen Pharmaceuticals

      • 14.3.1 Janssen Pharmaceuticals Company Details

      • 14.3.2 Janssen Pharmaceuticals Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Janssen Pharmaceuticals Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Product and Service

    • 14.4 Nordmark Arzneimittel

      • 14.4.1 Nordmark Arzneimittel Company Details

      • 14.4.2 Nordmark Arzneimittel Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Nordmark Arzneimittel Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Product and Service

    • 14.5 AzurRx Biopharma

      • 14.5.1 AzurRx Biopharma Company Details

      • 14.5.2 AzurRx Biopharma Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 AzurRx Biopharma Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Product and Service

    • 14.6 AbbVie

      • 14.6.1 AbbVie Company Details

      • 14.6.2 AbbVie Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AbbVie Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Product and Service

    • 14.7 Cilian

      • 14.7.1 Cilian Company Details

      • 14.7.2 Cilian Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Cilian Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Product and Service

    • 14.8 Anthera Pharmaceuticals

      • 14.8.1 Anthera Pharmaceuticals Company Details

      • 14.8.2 Anthera Pharmaceuticals Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Anthera Pharmaceuticals Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics

    • Figure Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Picture

    • Table Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption by Country (2017-2022)

    • Figure United States Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)

    • Table Europe Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure China Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Japan Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure India Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure United States Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Specialty Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Export by Region (Top 5 Countries) (2017-2028)

    • Table Allergan (Foundation Year, Company Profile and etc.)

    • Table Allergan Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Product and Service

    • Table Digestive Care (Foundation Year, Company Profile and etc.)

    • Table Digestive Care Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Digestive Care Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Product and Service

    • Table Janssen Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Janssen Pharmaceuticals Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Pharmaceuticals Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Product and Service

    • Table Nordmark Arzneimittel (Foundation Year, Company Profile and etc.)

    • Table Nordmark Arzneimittel Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nordmark Arzneimittel Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Product and Service

    • Table AzurRx Biopharma (Foundation Year, Company Profile and etc.)

    • Table AzurRx Biopharma Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AzurRx Biopharma Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Product and Service

    • Table Cilian (Foundation Year, Company Profile and etc.)

    • Table Cilian Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cilian Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Product and Service

    • Table Anthera Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Anthera Pharmaceuticals Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Anthera Pharmaceuticals Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US